Cite
2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in differentiated thyroid carcinoma: clinical indications and controversies in diagnosis and follow-up.
MLA
Salvatori, Massimo, et al. “2-[18F]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Differentiated Thyroid Carcinoma: Clinical Indications and Controversies in Diagnosis and Follow-Up.” European Journal of Endocrinology, vol. 173, no. 3, Sept. 2015, pp. R115–30. EBSCOhost, https://doi.org/10.1530/EJE-15-0066.
APA
Salvatori, M., Biondi, B., & Rufini, V. (2015). 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in differentiated thyroid carcinoma: clinical indications and controversies in diagnosis and follow-up. European Journal of Endocrinology, 173(3), R115–R130. https://doi.org/10.1530/EJE-15-0066
Chicago
Salvatori, Massimo, Bernadette Biondi, and Vittoria Rufini. 2015. “2-[18F]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Differentiated Thyroid Carcinoma: Clinical Indications and Controversies in Diagnosis and Follow-Up.” European Journal of Endocrinology 173 (3): R115–30. doi:10.1530/EJE-15-0066.